Compare GSK plc (GSK) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Utilities Select Sector SPDR Fund — how do they compare? GSK plc trades at $52.85 (market cap $101.34B), while Utilities Select Sector SPDR Fund trades at $45.49. The key difference: GSK plc pays a 3.49% dividend while Utilities Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| GSK | XLU | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | — |
52-Week High | $61.18 | $47.73 |
52-Week Low | $36.20 | $41.02 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
XLU trades at $45.26, down 0.94% amid a bearish technical signal with moving averages indicating selling pressure. The utilities ETF benefits from AI-driven power demand growth, with recent news highlighting its defensive characteristics and exposure to regulated utilities. Key support sits at $44-45 while resistance is at $46.
The outlook remains mixed with technical weakness offset by strong fundamental tailwinds from AI infrastructure demand. Investment opportunity lies in the sector's transformation from defensive to growth-oriented, though risks include regulatory changes and grid capacity constraints that could limit upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
